Laurie Connors speaks to ecancer about PARP inhibitors for prostate cancer.

She initially outlines how PARP, and PARP inhibitors work, as well a the history of their usage.

Laurie then explores some of the PARP inhibitors for prostate cancer that are currently approved, and what this means for treatment, but also testing of family members.

This programme has been supported by an unrestricted educational grant from Pfizer.